PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $101,000 | +2.0% | 32,038 | -6.0% | 0.00% | -100.0% |
Q2 2020 | $99,000 | +57.1% | 34,072 | +52.7% | 0.00% | – |
Q1 2020 | $63,000 | -51.5% | 22,307 | -44.2% | 0.00% | -100.0% |
Q4 2019 | $130,000 | +38.3% | 39,965 | -8.6% | 0.00% | 0.0% |
Q3 2019 | $94,000 | -40.1% | 43,749 | -12.6% | 0.00% | 0.0% |
Q2 2019 | $157,000 | -35.1% | 50,043 | -23.2% | 0.00% | 0.0% |
Q1 2019 | $242,000 | +29.4% | 65,177 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $187,000 | -7.4% | 64,580 | -15.9% | 0.00% | 0.0% |
Q3 2018 | $202,000 | +4.1% | 76,832 | -7.3% | 0.00% | 0.0% |
Q2 2018 | $194,000 | -27.3% | 82,869 | -8.8% | 0.00% | -50.0% |
Q1 2018 | $267,000 | -8.9% | 90,848 | -14.9% | 0.00% | 0.0% |
Q4 2017 | $293,000 | -12.5% | 106,779 | +8.0% | 0.00% | -33.3% |
Q3 2017 | $335,000 | +38.4% | 98,858 | +1.0% | 0.00% | +50.0% |
Q2 2017 | $242,000 | -2.8% | 97,908 | -10.6% | 0.00% | -33.3% |
Q1 2017 | $249,000 | -14.4% | 109,517 | -20.2% | 0.00% | 0.0% |
Q4 2016 | $291,000 | -28.9% | 137,310 | +12.4% | 0.00% | -50.0% |
Q3 2016 | $409,000 | -9.9% | 122,120 | -15.6% | 0.01% | 0.0% |
Q2 2016 | $454,000 | -4.4% | 144,626 | +1.4% | 0.01% | -14.3% |
Q1 2016 | $475,000 | -13.6% | 142,661 | -8.2% | 0.01% | 0.0% |
Q4 2015 | $550,000 | -22.4% | 155,432 | +10.3% | 0.01% | -30.0% |
Q3 2015 | $709,000 | -31.4% | 140,874 | -12.4% | 0.01% | -28.6% |
Q2 2015 | $1,034,000 | -13.8% | 160,764 | -5.8% | 0.01% | 0.0% |
Q1 2015 | $1,200,000 | +4.3% | 170,605 | +14.4% | 0.01% | +7.7% |
Q4 2014 | $1,150,000 | +1.5% | 149,109 | -1.7% | 0.01% | -13.3% |
Q3 2014 | $1,133,000 | -35.7% | 151,690 | -16.6% | 0.02% | -34.8% |
Q2 2014 | $1,761,000 | -16.6% | 181,953 | -28.4% | 0.02% | -11.5% |
Q1 2014 | $2,111,000 | +227.8% | 254,010 | +232.7% | 0.03% | +160.0% |
Q4 2013 | $644,000 | -42.8% | 76,341 | -46.0% | 0.01% | -63.0% |
Q3 2013 | $1,126,000 | +20.6% | 141,289 | +16.8% | 0.03% | +50.0% |
Q2 2013 | $934,000 | – | 120,966 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |